Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for EPCLUSA
- Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis
- Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%
- Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
- Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)
- Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19
- Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir
- A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients
- Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil
- Micro-elimination of Hepatitis C Virus Infection in Uremics
- Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3)
- The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients
- The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients
- Utilization of Hepatitis C Positive Kidneys in Negative Recipients
- Transplanting Hepatitis C Lungs Into Negative Lung Recipients
- Hepatitis C Positive Donor Into Hepatitis C Negative Recipients
- HCV Seek, Test and Rapid Treatment for Young PWID
- Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant
- Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy
- People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
- Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole.
- Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection
- Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)
- A TEst and Treat Intervention aMong Current People Who Inject Drugs With HCV Attending Needle and Syringe PrOgrams
- Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet
- Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
- Expanding the Pool in Lung Transplantation
- HCV Post-Exposure Prophylaxis for Health Care Workers
- A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic
- Expanding the Pool in Orthotopic Heart Transplantation
- Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment
- Lung Transplant HCV, Pilot Study
- Transplanting Hepatitis C Positive Thoracic Organs
- Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection
- Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial
- Curing HCV in Incarcerated Patients
- Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV Infection
- Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia
- Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients
- Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor
- Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study
Clinical trials list
click for details